We here review experimental findings relevant for the pharmacology of conscious experience, an issue largely neglected in pharmacological research. First, we focus on self-awareness, a pivotal component of conscious experience and its integration within the global neuronal network (GNW), a theoretical concept that unifies convergent approaches on the neural bases of conscious processing. We report recent evidence to show that self-awareness mobilizes a paralimbic circuitry of ␥ synchrony, and that such synchrony is, in particular, regulated by GABA interneurons under the control of acetylcholine and dopamine. Recent data illustrate that these neurotransmitters establish a causal relationship with the control of self-awareness. The hypothesis is presented that not only is self-awareness chemically regulated, but the reverse may be true. Long-term deficit in self-control of drug intake would result in compulsive substance use, accompanied, in particular, with lesions of the paralimbic circuitry of self-awareness, leading to aggravation of substance abuse, resulting in addiction in a vicious circle. Finally, we propose that the emergent pharmacology of conscious experience may provide new perspectives, not only in substance addiction but also in the many other pathological conditions with deficient self-awareness.-Changeux, J. -P., Lou, H. C. Emergent pharmacology of conscious experience: new perspectives in substance addiction. FASEB J. 25, 2098 -2108 (2011). www.fasebj.org Key Words: global neuronal workspace ⅐ self-awareness ⅐ selfregulation ⅐ GABA ⅐ interneurons ⅐ acetylcholine ⅐ dopamine 2098 0892-6638/11/0025-2098 © FASEB
In the course of biological evolution, the survival of individual organisms became increasingly dependent on a broader diversity of stimuli and response pathways to fulfil their behavioral needs. A parsimonious solution to this difficulty was to guide decision making from the multiple wants and feelings of reward through a common mental workspace (1) . On this basis, Baars (2) suggested a psychological model that postulates that the current conscious content is represented within a distinct mental space called "global workspace" with the capacity to broadcast information to underlying special-ized nonconscious processors. Dehaene, Changeux and collaborators further proposed a hypothetical neuronal architecture, referred to as the global neuronal workspace (GNW) model (3) (4) (5) (6) , based on a brain-wide subset of reciprocally connected cortical pyramidal neurons with long-range excitatory axons-together with their thalamocortical relationships-particularly dense in prefrontal, parietotemporal, and cingulate regions. This global neuronal network would interconnect the multiple nonconscious processors and broadcast late, all-or-none and sustained firings of a fraction of GNW neurons, associated with enhanced ␤ and ␥ synchrony (7, 8) referred to as "ignition" (9) . In these circumstances, the nonamplified neurons would be inhibited and the GNW sustained activity would encode the conscious content. Access to the GNW has been implemented as explicit computer simulations of defined neural networks and has received empirical support from a variety of physiological recordings by positron emission tomography (PET), functional magnetic resonance imaging (fMRI), event-related potential (ERP), magnetoencephalography (MEG), and single-cell electrophysiology (4) . From the start, the GNW model unambiguously distinguishes the neuronal mechanisms, neurotransmitter systems and their pharmacology involved in the regulation of the states of consciousness (i.e., sleep and wakefulness, coma) and in the processing of conscious information.
In this review, we address new experimental findings relevant for the pharmacology of conscious experience, an issue largely neglected in consciousness research. First we focus on self-awareness, a pivotal component of conscious experience and its integration within the GNW. We report recent evidence that self-awareness is determined by a paralimbic circuitry characterized by ␥ synchrony, and that such synchrony is regulated by GABA interneurons controlled by, in particular, acetyl- 1 These authors contributed equally to this work. 2 Correspondence: J.P.C., Institut Pasteur, 28 choline and dopamine. Accordingly, circumstantial and direct evidence suggests that these neurotransmitters are prime regulators of conscious experience. We hypothesize that not only is conscious experience chemically controlled; but that the reverse could also be true, specifically in the case of substance abuse where the chemical homeostasis of the brain is altered due to deficient conscious self-regulation of substance intake. Long-term insufficient self-control results in compulsive use, accompanied, in particular, with lesions of the paralimbic circuitry of self-awareness, leading to aggravation of substance abuse, resulting in addiction in a vicious circle. Finally, we propose that the emergent pharmacology of conscious experience may also prompt the development of new perspectives in the many other conditions characterized by altered conscious experience, leading to improved and individualized therapy.
␥ SYNCHRONY IN CONSCIOUS PROCESSING
Neuronal oscillatory firings in the brain are currently recorded by a variety of methods, including electroencephalography (EEG) and MEG, and the synchronization of these firings is thought to strengthen the formation of neuronal assemblies. In particular, fast oscillation in the ␥ range (30 -100 Hz) is viewed as a vehicle for tight temporal organization of the interaction between far distant neurons. The ␥ oscillations indeed enhance cortical transmission by reducing signal to noise ratio and by improving temporal coordination between widely distributed neural assemblies such as in the paralimbic circuitry of ␥ synchrony in selfawareness (10) . The oscillatory events in the ␥ range in the brain vary with the states of consciousness, being highest during wakefulness, intermediate during rapid eye movement (REM) sleep, and lowest during slowwave sleep (11) . In a seminal paper, Rodriguez, Varela, and coworkers (8) demonstrated a correlation between ␥ synchrony and conscious perception of so-called Mooney faces. They showed that long-distance synchrony of ␥ oscillations (30 -80 Hz) is elicited during processing of recognizable faces compared to inverted or scrambled faces. The authors proposed that such fast oscillatory activity could be an integrative mechanism for widely distributed neurons to constitute a coherent neuronal ensemble underlying conscious processing (7, 12, 13) . It was recognized that localized ␥-band oscillations can also be evoked by nonconscious stimuli at the early stages of stimulus processing (7, 13) .
High-frequency synchrony thus appears to be a tool for temporal integration. Yet there are important limitations to this research. For one thing, the origin of sources of electromagnetic signals is imprecise, due to their overlap, imposing severe limits to connectivity measures. To counteract this limitation, there is currently a rapid development of mathematical tools to improve the spatial resolution of signal origin, such as the beam former analysis (14) . Also, perhaps even more tantalizing is the conceptual problem in ascribing causality to a purely correlative signal. In the following section, we show that this limitation may be circumvented with transcranial magnetic stimulation (TMS).
␥ SYNCHRONY IN SELF-AWARENESS AND SELF-REFERENCE
Concurrent with this development, empirical advances have been made to identify the neural contribution to self-awareness and the GNW. An early PET study of self-generated actions revealed concurrent hemodynamic activity in the posterior cingulate cortex, suggesting the existence of a self-regulating monitoring system (15) . Damasio stressed the distinction between a "core consciousness" (core self) and an "extended consciousness" (extended self) (4, 16) , in analogy with the terms "minimal self" and "extended self" (17) . The minimal self-awareness is prereflexive, immediate, and normally infallible, while still involving a sense of ownership of experiences (17) . The "extended self" is a coherent self across time and requires a system to retrieve memories of personal experiences: episodic memory (18) . Consequently, episodic memory retrieval becomes an indispensable component of the more complex forms of self-awareness and consciousness, which are described in various terms, such as extended self, autonoetic consciousness, narrative self, or "meta-knowledge," i.e., the knowledge that participants know they possess (18) . In this review we use the terminology as defined by Gallagher (17) . When compared to third person, both minimal self-awareness and extended self-awareness are linked to hemodynamic activity in a medial paralimbic circuitry. This circuitry involves medial prefrontal/ anterior cingulate, medial parietal/posterior cingulate, and subcortical regions ( Fig. 1) . It is associated in with the lateral parietal cortex, typically the angular gyri, and insula (19 -23) . Besides being active in self-awareness, it was of decisive importance to determine whether this circuitry is effective in self-awareness. To this end, we used transcranial magnetic stimulation (TMS) to transiently disturb neural activity in key cortical regions of the circuitry. The studies showed that TMS indeed selectively impeded self-processing when targeting the circuitry (20, 24) , an effect confirmed and extended in another laboratory (25) . Accordingly, the paralimbic circuitry would play a causal role in generating self-awareness. An early study with a selected population of subjects, such as highly experienced yoga practitioners, has shown that activity patterns of polymodal cortical association regions vary greatly with the changing contents of consciousness. By contrast, there is a sustained activity in paralimbic prefrontal/anterior cingulate and parietal/posterior cingulate regions in the midline. This led to the hypothesis that the medial paralimbic regions contribute to the unity of conscious experience by acting as a common reference of self-perspective for changing contents (26, 27) .
Each structure in the paralimbic circuitry contributes fundamental properties of extended self-awareness (21) . The medial prefrontal cortex, including the orbitomedial prefrontal and anterior cingulate gyrus, is a region classically involved in self-reference, with convergence of interoceptive and exteroceptive stimuli and self-regulation (15, 22) . The frontal monitoring and evaluative functions of self-awareness are complemented by functions in the posterior midline establishing spatial and diachronic unity of self and of consciousness. Spatial organization involves posterior cingulate/medial parietal cortex active in linking new information with prior knowledge on the subject matter (28) . In autonoetic consciousness, this region is effective in retrieval of episodic memory for autobiographical self-consciousness (21) .
The interaction between the paralimbic regions is characterized by increased ␥ synchronization, in particular during explicit self-processing, like introspection, while self-processing during minimal self-reference is only weakly associated with ␥ synchrony. Introspection was studied with MEG during retrieval of previous judgment of the fitting to oneself of serially presented adjectives, while minimal self-reference required counting the number of syllables in a series of similar adjectives. The degree of self-processing is therefore linked to the degree of ␥ synchrony in the circuit. The paralimbic ␥ synchronization would thus enable unity of consciousness through coherence of serial conscious experiences by acting as their common neural path (29, 30) . Hemodynamic studies indicate that this paralimbic circuit interacts with the cortical association regions in a constantly changing pattern, depending on the shifting content of consciousness (24, 26) . In explicit introspection, this content will be dominated by self-reflection. The long-range ␥ synchronization of the self-awareness paralimbic circuitry, common to a wide variety of conscious experiences and connected to changing patterns of association cortices according to the shifting content, is thus consistent with the GNW model (4). The paralimbic circuitry of self-awareness would thus be seen as a common neural path of a number of influences on self-control, including, among others, emotion, stress, and reward. The pivotal role for ␥ synchrony in self-awareness and self-control (31) is reflected in the fact that ␥ synchrony is disturbed both locally, in a paralimbic circuit including prefrontal and parietal cortices in borderline personality disorders (BPDs) characterized by lack of emotion regulation and impulse control (32) , and globally, in a major psychosis such as schizophrenia (33) .
Within this framework, we now examine the contribution of neurotransmitter activity to conscious processing and self-conscious experience. Recent empirical work has shown that ␥ synchrony between neuronal populations is regulated, in particular, by GABA, acetylcholine, and dopamine. Acetylcholine and dopamine activate receptors on GABA interneurons, which in turn regulate ␥ synchrony, and conscious experience, via rhythmic inhibition of pyramidal cells.
GABA INTERNEURONS REGULATING ␥ SYNCHRONY AND CONSCIOUS EXPERIENCE
It is currently accepted that in the cortex, ␥ oscillations arise from the inhibition of glutamatergic pyramidal cells by fast-spiking GABA interneurons (34) . GABA interneurons constitute ϳ25% of cortical neural cells and are prime regulators of oscillatory synchrony of pyramidal cells. Pyramidal cells outnumber interneurons by a factor of 3 to 1. The GABA interneurons orchestrate the synchronization of neuronal assemblies via "hub" neurons, establishing long-range connections linking large number of cells through GABA receptor activity and/or direct electric conductance (gap junctions; ref. 35 ). GABA neuron-mediated pyramidal cell synchronization occurs when interneurons fire, mostly via fast synaptic inhibition involving primarily postsynaptic GABA receptors.
In addition to their contribution to the regulation of cortical pyramidal cell synchronization, one should as well mention the role of the GABAergic neurons of the reticular thalamus and their cholinergic afferents from the brainstem (laterodorsal and pedunculopontine tegmental nuclei) and basal forebrain (nucleus basalis of Meynert, band of Broca) in regulating conscious states (4, 36) .
Furthermore, during early human development, the GABAergic function undergoes remarkable changes. While the GABA system is a dominant inhibitory neurotransmitter throughout most of the human life span, this is not the case during the early few months when the GABA system is mostly excitatory (37) . Consonant with this, and the decisive function attributed to GABAergic inhibition in neural synchronization, ␥ synchrony is not apparent in early infancy. It develops gradually throughout infancy, childhood, and adolescence (38) . In agreement with the attribution of these neurobiological events to self-awareness, self-awareness, in its turn, gradually develops from an early ecological sense of self through self-exploration and mirror recognition into extended self-awareness, with autism spectrum disorders or schizophrenia as a result of its default (38, 39) .
Several pharmacological effectors of postsynaptic GABA-A receptors are known to affect ␥ synchrony and thus conscious experience (Fig. 2) .
GABA-A receptors are allosteric membrane proteins that carry a chloride-selective ion channel, which rapidly opens on GABA-binding (at variance with GABA-B receptors that are G-protein-linked receptors; refs. 40, 41) . As a consequence of chloride entry into the pyramidal cell, the postsynaptic membrane hyperpolarizes, creating an inhibitory postsynaptic current (IPSC) that contributes to pyramidal cell silencing. The GABA interneurons typically establish multiple synapses with each pyramidal cell, along with neighboring pyramidal neurons and interneurons, and the efficiency of the system depends on the excitation of the interneurons by glutamate release (10) . Such glutamate action may be generated in the neocortex via feedback from the pyramidal cells, typically causing rhythmicity in the pyramidal cells in the low ␥ range (14) . As discussed below, GABA interneurons are also activated by acetylcholine and dopamine receptors, which, as a consequence, may indirectly regulate ␥ synchrony (42, 43) and self-awareness (29) (Fig. 2) .
GABA neuron-mediated ␥ synchrony in the neocortex is a target of pharmacological agents acting on GABA A receptors, in particular, general anesthetics (44 -46; Fig. 3 ). The general anesthetic thiopental disrupts ␥ oscillations on hippocampal slices, while the benzodiazepine diazepam, a positive allosteric modulator of GABA A receptor, had little effect at the concentration tested (47) . The general anesthetic propofol also reduces ␥ synchrony (48) . At high doses, the benzodiazepine midazolam (0.2mg/kg) causes general anesthesia with loss of consciousness. Using TMS in combination with high-density EEG, Ferrarelli et al. (49) monitored long-range interactions between multiple cortical areas (lasting Ͼ300 ms) that they refer to as cortical effective connectivity. They found decreased duration of TMS-triggered responses during midazolam-elicited loss of consciousness. Generally speaking, and in agreement with the GNW model, pharmacological agents acting on GABA receptors affect long-range synchrony and, as a consequence, alter conscious experience.
A paradoxical opposite effect of "awakening from coma" is noted with zolpidem, a nonbenzodiazepine drug belonging to the imidazopyridine class and used for the therapy of insomnia. Zolpidem, like benzodiazepines, is a positive allosteric modulator of GABA A receptor. The majority of GABA A receptors containing ␣ 1 , ␣ 2 , ␣ 3 , or ␣ 5 subunits are benzodiazepine sensitive, with the benzodiazepine binding site located at the boundary between ␣ and ␥ subunits in the extracellular domain of receptors containing both subunits. But there also exists a minority of GABA A receptors containing ␣ 4 or ␣ 6 subunits, which are insensitive to classic 1,4-benzodiazepines (50) . The benzodiazepines bind nonselectively to GABA A receptors, whereas zolpidem binds preferentially, if not exclusively, to ␣1-subunitcontaining GABA A receptors. While benzodiazepines, as mentioned, cause a loss of consciousness in high doses, zolpidem was accidentally discovered to have the unexpected effect of waking up patients who have been in a chronically vegetative or minimally conscious state (51) . Moreover, the patients return to their comatose state after the lapse of drug action and reawaken from their coma after renewed drug application. The finding has been confirmed in 10 of 23 neurologically dependent patients (52) . Another GABAergic compound, baclofen, has also been reported to arouse patients from the vegetative state. Baclofen is an agonist of the GABA B metabotropic receptors and is primarily used for the treatment of spasticity after spinal cord injury (51) . This arousing effect is not seen with nonselective benzodiazepines.
Complementing the positive effect of zolpidem in humans, it has been found that pharmacologically enhancing GABAergic transmission in the pontine reticular formation (PnO) of cats, rats, or mice increases wakefulness and decreases sleep (53) . On the other hand, blocking GABA A receptors in the PnO, for instance with the antagonist bicuculline (53), decreases time spent in wakefulness and increases time spent in REM sleep (54) . GABAergic transmission also modulates the release of other neurotransmitters in the PnO that regulate sleep and wakefulness. For example, acetylcholine in the PnO promotes REM sleep (55) (56) (57) , and direct administration of bicuculline to PnO in cats increases ACh release and triggers the onset of REM sleep (56) . Together, these pharmacological data support the interpretation that enhanced GABAergic transmission promotes wakefulness. Moreover, studies using intracranial drug administration have revealed that depending on brain site of action, GABA A receptor agonists, antagonists and endogenous GABA differentially alter sleep and wakefulness (54) .
Zolpidem has been interpreted by Schiff (58) to of cortical neurons, are exhibiting ␥ synchrony for interaction between cortical regions, i.e., in the paralimbic circuitry of self-reference (19, 20) . Fast-spiking GABAergic neurons are responsible for this synchrony by inhibitory influence on pyramidal cell excitation. In turn, interneuron activity is enhanced by acetylcholine (muscarinic) receptors and dopamine D1 and D2 receptors located at or near the soma. By this common path, acetylcholine and dopamine both enhance paralimbic synchrony for self-reference, a crucial constituent of any conscious experience. Modified from Gonzalez-Burgos and Lewis (14), with permission.
inhibit the globus pallidus interna neurons that tonically inhibit the central thalamus, thus producing EEG and behavioral activation. We may suggest an alternative hypothesis, inspired by the observation that GABAergic transmission within the PnO promotes wakefulness, according to which zolpiden would promote wakefulness by selectively potentiating GABA A receptors in the PnO (54) . This interpretation requires that the GABA A receptors in PnO preferentially contain the ␣1 subunit that specifically interacts with zolpiden, a precondition that remains to be tested. In the two following sections, we examine how acetylcholine and dopamine can regulate ␥ synchrony via their receptors present on the GABA interneurons.
ACETYLCHOLINE REGULATING GABA INTERNEURONS, ␥ SYNCHRONY, AND CONSCIOUS EXPERIENCE
In the mammalian brain, acetylcholine activates 2 classes of receptors, the metabotropic muscarinic ace-tylcholine receptors, and the ionotropic nicotinic receptors. Molecular cloning has identified 5 muscarinic receptors, of which 3 are coupled to Gq proteins that activate phospholipases and mobilize intracellular Ca 2ϩ , and 2 are coupled to Gi/o proteins inhibiting adenyl cyclase, thereby reducing cyclic AMP formation and inhibiting Ca 2ϩ channels. M1, the dominant class of muscarinic receptors, is highly expressed in glutamatergic pyramidal neurons, but is not distributed closely to synapses, suggesting an activation by nonsynaptic volume transmission (59) . The M4 class has been reported to participate in the regulation of dopaminergic neurotransmission (60) .
Nicotinic receptors are ligand-gated ion channels composed of 5 subunits arranged like staves in a barrel around a central cationic pore (61). The regional distribution of nicotinic receptors in the brain is complex due to the broad diversity of receptor subtypes. Also, their subcellular localization varies with neuronal categories and receptor subtype (62) . Of special interest for the generation of ␥ synchrony is the finding that A) The neurotransmitter GABA (violet) and its homologue orthosteric ligands bind to defined subunit interfaces in the extracellular (synaptic) domain; the benzodiazepine (red) site is located at nonconventional subunit interfaces of the extracellular domain; the allosteric site for general anesthetics, here etomidate (brown), is present within the transmembrane domain (40, 41) . B) a) The pentameric receptor channel from the bacteria Gloeobacter violaceus is a close structural homologue of brain neurotransmitter-gated ion channels like the nicotinic acetylcholine or GABA receptors (45, 46) . b) The general anesthetic (propofol, desflurane) binding site is located within the transmembrane domain near the interface with the extracellular domain and in close relationships with membrane lipids, which may behave as endogenous ligands (45, 46) . Reproduced from Li et al. (40) and Nury et al. (45) . excitatory, glutamatergic transmission in prefrontal cortex is enhanced by acetylcholine nicotinic agonists but decreased by muscarinic agonists (63, 64) . As a consequence, ␥ synchronization may increase during cholinergic stimulation. Conversely, ␥ synchronization may be nearly abolished by application of scopolamine, inhibiting response to acetylcholine of muscarinic receptors (43) . Consistent with this finding, neuronal synchrony is markedly increased by muscarinic agonists (65) . Léna et al. (66) found that some nicotinic receptors are distributed not only on the neuronal soma and dendrites, but also on axonal terminals and at the "preterminal" level on the noeuds de Ranvier of myelinated axons (67) , suggesting that long-distance axons (and thus white matter) may be under the control of acetylcholine (68) .
The significance of the cholinergic system for control of cognition is supported by in vivo pharmacological and behavioral experiments with selective antagonists of nicotinic and muscarinic receptors. The data reveal distinct contributions of nicotinic and muscarinic receptors in memory processing and delayed response tasks in rats (69) . Recent studies in mice involving deletion and stereotactic reexpression of genes for defined nicotinic receptor subunits have led to the indentification of molecular building blocks of nicotine reward and addiction (70) , together with the contribution of defined nicotinic receptor oligomers to the access of distinct states of vigilance and sleep and to global behavioral integration, including behavioral flexibility (71) (72) (73) .
Also, the general anesthetic sevoflurane alters exploratory and anxiety-like behavior in mice lacking highaffinity nicotinic receptors (74) . Deficient reward has been demonstrated by deletion of the nicotinic receptor ␤2 subunit. Its reexpression in the ventral tegmental areas unequivocally establishes that nicotine interacts with the dopamine system via nicotinic acetylcholine receptors, thereby directly regulating dopaminergic firing in the ventral tegmental area and substantia nigra, and thus dopamine release in terminal fields. Local application of nicotine to nucleus accumbens and dorsal striatum also increases dopamine overflow (75) . As mentioned in the introduction, there appears to exist a fundamental link between feeling of reward and conscious experience. These data are therefore consistent with neurotransmitter regulation of conscious experience with a defined pharmacology.
DOPAMINE IN CONSCIOUS EXPERIENCE
Prefrontal cortical neurons are modulated by dopamine signaling through D1 and D2 receptors (76, 77) , and D4 receptors are abundant in GABA interneurons from the primate brain (77) . Yuen and Yan (77) found that D4 activation causes a persistent suppression of AMPAR-mediated synaptic transmission in prefrontal cortical interneurons, indicating that D4 receptors may control GABAergic inhibition in the prefrontal cortical network (77) . In slices of primate dorsolateral prefrontal cortex, dopamine increases inhibition of pyramidal cells via a presynaptic action-potential-dependent mechanism through D1 but not D2-receptors. This action on prefrontal pyramidal neurons is mediated by fast-spiking GABA interneurons that express the calcium-binding protein parvalbumin (42) . Dopaminergic activation via D1 and D4 receptors regulates receptors in GABAergic interneurons and stimulates GABAergic prefrontal cortical inhibition (42, 77) . As a consequence, dopamine release increases ␥ synchrony and thereby regulates the cognitive functions, including self-reference (29) . This interpretation is strengthened by the finding that the 10/10 genotype of the dopamine transporter (DAT) is specifically associated with a reduction of DAT expression, and thereby with an increase of extracellular dopamine concentration, and that the DAT 10/10 genotype is linked to evoked ␥ synchrony as a response to target stimuli (78) .
A causal role for dopaminergic neurotransmission in conscious experience and the conscious state is further suggested by clinical observations, such as abnormal conscious experiences like hallucinations that are core positive symptoms in acute schizophrenia. Functional brain imaging has also revealed their association with abnormal dopaminergic neurotransmission. For instance, striatal DAT availability is inversely correlated with hallucinations in schizophrenia (79) . Moreover, dopaminergic agents, in parallel to zolpidem, are sometimes effective in awakening patients with disorders of consciousness. For instance, Matsuda et al. (80) described 5 patients in the vegetative state who responded to l-DOPA. Similarly, the dopamine agonist bromocriptine improved awareness in 5 patients who were in the vegetative state after traumatic brain injury (81) . Finally, the dopamine agonist apomorphine has been shown to arouse a patient from the minimally conscious state (82) .
In healthy subjects, enhanced sensory experience during yoga nidra meditation is linked to dopamine release in the ventral striatum (83) . Recently, Lou et al. (84) have reported improved confidence and accuracy in seeing rapidly presented words in a controlled study with the D1 and D2 dopamine receptor agonist pergolide. This observation shows unequivocally that conscious experience is transmitter regulated and provides strong evidence for a causal role of dopamine. A plausible target for dopamine action is the midbrain superior colliculus, a primary visual structure, specialized for the detection of rewarding (85), unexpected, and salient stimuli (86) . It is reached directly both by visual pathways and by projections from the substantia nigra pars compacta (86) . The latency of this circuitry is rather short, ϳ100 ms, as measured by light flashes during a collicular microinjection of bicuculline (87) . Within this time scale, dopaminergic neurons respond to a visual event even before the onset of a visual saccade, and before the stimulus is in focus (87) . The effect of dopamine on word processing is thus expected to take place during preattentive nonconscious process-ing, within delays shorter than the time of ϳ500 ms required for access to consciousness (4, 88) .
In summary, we have illustrated how neurotransmitters may control conscious experience to the extent that we may now explore the plausibility of an interaction in the opposite direction: how drugs may cause toxic lesions in brain networks, resulting in impaired self-regulation and long-term alteration of chemical homeostasis in the brain, leading to substance addiction.
ADDICTION AS A SYNDROME OF PARALIMBIC AND GNW DISCONNECTION?
Substance addiction can be viewed as the end point of a series of transitions from initial voluntary substance use to the complete loss of conscious "voluntary" control over this behavior, such that it becomes habitual and, ultimately, compulsive. Addiction is often conceptualized as deficiency of self-regulation, impulse control, decision making, and emotion processing (89) . The addicted subject loses conscious self-regulation of behavior, i.e., will power. Moreover, when deprived of the substance, the addicted subject shows cognitive impairments on tasks like the Stroop task that require the suppression of task-irrelevant information, decision making, and working memory (90, 91) . Substance addiction shares many symptoms with both BPDs (32) and adult attention deficit/hyperactivity disorder (ADHD; ref. 92) to the extent that these conditions are commonly grouped together as "impulse control disorder" (ICD). It is of particular interest for the present discussion that deficient impulse control in BPDs has been directly linked to impairment of paralimbic ␥ synchronization (32) .
The cognitive deficits associated with substance addiction have not yet been investigated with the methods used to monitor access to consciousness (4) . In particular, data on ␥ synchrony in patients with substance addiction are lacking. Yet, similarities have been noted in their cognitive dysfunction with patients having orbitomedial prefrontal cortex damage of different etiologies (93) . The orbitomedial prefrontal cortex being a key region in self-reference and self-regulation, this may suggest that such dysregulation is at the core of the addiction syndrome. Moreover, tobacco smokers with brain damage involving the insula were much more likely to quit smoking than smokers with brain damage not involving the insula (94) . The insula is known to be involved in interoceptive awareness of one's own body, in particular, with negative emotional valence. The insula sends excitatory projections to the nucleus accumbens and acts in concert with regions that are involved in maintaining specific goals, such as the dorsolateral prefrontal cortex. During substance addiction, procuring the substance becomes an overriding goal when unchecked by self-regulation. Nicotine might thus impair the GNW, perverting decision making in order to seek and procure substances, thereby hijacking inhibitory control to resist drug use.
The reciprocity between self-regulation and goal-directed action has been described extensively in the literature (e.g., ref. 95) . The preferential impairment of the paralimbic regions in long-term addiction is thus consistent with the hypothesis that substance abuse is a symptom of impaired conscious self-control. These views are consonant with those presented in previous sections on the causal role of the paralimbic medial circuitry in self-reference and self-regulation (19 -24) . The long term switch from voluntary drug consumption to habitual and progressively compulsive drug use would therefore represent a global and poorly reversible transition from conscious self-awareness in the GNW to unchecked goal-directed action (96) . A hypothesis of a pharmacological disconnection from a top-down GNW processing may thus be suggested (70) .
Consistent with this hypothesis, a variety of diffusion tensor imaging studies reveal a reduction of fractional anisotropy, and thus a selective disruption in white matter integrity, as a consequence of long-term substance addiction. Reduced cerebral blood flow and brain glucose metabolism, primarily in the frontal cortex, have been reported in subjects with cocaine dependence subjects (97), together with deficits in abstracting and problem-solving abilities (98) believed to be mediated by the prefrontal cortex (99) . Diffusion tensor imaging revealed a reduction of fractional anisotropy, and thus a selective disruption in white matter integrity, in the inferior frontal brain regions, suggesting a critical role for the orbitofrontal cortex in addiction-related phenomena and maladaptive decision making (100) . Methamphetamine abusers also exhibit reduced fractional anisotropy in the anterior callosal white matter microstructure linked to impaired response on the Stroop test (101) . In the case of chronic alcohol consumption, diffusion tensor imaging identified lower fractional anisotropy in regions of specific fiber bundles within the frontal white matter (102) . In another study, such damage has been demonstrated in corticostriatal fibers and in frontal white matter and limbic pathways, as well as in commissural fibers (103) . These findings provide direct evidence of compromised integrity of the self-regulatory brain circuitry in alcohol abuse. Similarly, subjects with heroin dependence (104) showed reduced fractional anisotropy located in the bilateral frontal subgyral regions, right precentral and left cingulate gyrus. Voxelwise and tractography analyses of young adult males in residential treatment for cannabis dependence revealed reduced fractional anisotropy, increased radial diffusion, and increased trace, particularly in the frontotemporal connection via arcuate fasciculus (105) .
From the description above, it is clear that there is a strong link between substance abuse and long-tract paralimbic pathology, involving the circuitry of selfawareness and self-control. Recent data indicate that substance abuse is indeed causal in this link. In tobacco addiction, prenatal and adolescent exposure to tobacco smoke has been reported to modulate the development of white matter microstructure (106) . A direct action of nicotine on axon conduction at the level of nicotinic receptors present at the noeuds de Ranvier appears plausible (66 -68) . In particular, nicotine stimulation of thalamocortical axons in rat and mouse slices elicits a large increase in glutamate release onto pyramidal neurons from prefrontal (67) or auditory thalamocortical pathways thus opening the possibility of a direct control of the GNW by nicotine and addictive drugs in general. Consistent with this interpretation, corticothalamic connectivity is found vulnerable to nicotine exposure during early postnatal development through ␣4/␤2/␣5 nicotinic acetylcholine receptors in mice (68) . These observations thus make plausible a direct control of the GNW by nicotine at the white-matter level (66, 68, 106, 107) . They are also consonant with the physiological and behavioral observations of functional nicotinic acetylcholine receptors on prefrontal cortical neurons (63, 69) . They are in agreement with the proposal of a gating circuit modulating in a topdown manner the activation of the ventral tegmental area reward systems by nicotine and engaged in the volitional consumption of nicotine in the awake animal (69, 70) . At the level of the GNW, a functional link would additionally become established between nicotine self-administration and the norepinephrin/hypocretin controlled states of wakefulness (70) .
All these abnormalities in medial long-range fiber connections appear to be examples of neurotoxic effects of substance abuse, leading to further aggravation of deficient self-regulation and accelerated substance abuse in a vicious circle (Fig. 4) .
CONCLUSIONS AND PERSPECTIVES
In our pharmacological approach of conscious experience and self-awareness, evidence is first presented to illustrate that self-awareness, and self-control, may be viewed as integral components of both conscious experience and reward. The mobilization of a paralimbic circuit of ␥ synchrony is considered a common neural event, causally linking a wide variety of conscious experiences within a GNW network. ␥ synchrony, and, consequently, its associated cognitive functions, such as self-awareness and conscious experience, are also shown to be regulated by neurotransmitter activity, for instance, through dopamine and acetylcholine receptors on GABA interneurons.
These views offer a useful framework for future research on conscious experience and its pharmacology. In particular, it suggests the following experimental headlines:
A closer investigation of the noticed anatomical and physiological relationship between conscious experience and reward (in particular, through dopamine release) in the developmental evolution of self-awareness and GNW (1, 108) .
Further studies to provide new insights in the neural circuits of self-reference, including, in particular, meditation among multiple behavioral paradigms.
A detailed description of neurotransmitter regulation and pharmacology of conscious experience, in particular, of GABA interneurons and their control by acetylcholine, dopamine, and their receptors.
A deeper experimental approach based on our novel conceptual framework that substance abuse is a pharmacological disorder of self-awareness and self-reference. The different types of self-regulation and failure of self-control and self-awareness that may be impaired in drug addiction include the pleasurable effects of drugs when exposed to the reward and to the cues and the motivational states for the pleasurable effects of drugs that become even more pleasurable, but also the experiencing of negative emotional states, such as failure to self-regulate strength, problems in monitoring (rumination), and misregulation (overgeneralization). The present hypothesis of self-awareness and self-control might thus reconcile the "dark" side and the "light" side of addiction (36) . Specifically, our proposal that substance addiction may advance to a poorly reversible self-destructive disorder can now be tested. The toxic effects of substances may, for instance, damage long tracts in the paralimbic region, leading to impaired self-regulation, with disturbed chemical homeostasis of the brain, and further deleterious effects on self-regulation.
At the clinical level, the use of currently available methods to treat dysfunctions of conscious experience in hypoxic-ischemic encephalopathy, epilepsy, autism, ADHD, schizophrenia, Alzheimer disease, and substance abuse, to name some of the most important. We anticipate that individualized identification of defective neurotransmitter pathology might ultimately lead, in a near future, to improved and individualized therapies. Vicious circle of deficient self-awareness and enhanced substance addiction. Hypothetical interaction between decrease of self-awareness and self-control on one hand, and increase in substance abuse and addiction on the other, appears to be reciprocal and reinforcing in both directions.
